Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.75 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL791244 | 0.89 | MAPK1 (0.79) | MAPK1NOD2ALDH1A1THRBSMN1; SMN2 | |
| SCHEMBL17289545 | 0.88 | MAPK1 (0.59) | MAPK1NOD2ALDH1A1THRBKDM4E | |
| SCHEMBL13575286 | 0.86 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBSMN1; SMN2 | |
| SCHEMBL14520991 | 0.86 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBSMN1; SMN2 | |
| SCHEMBL15504324 | 0.86 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBSMN1; SMN2 | |
| SCHEMBL163843 | 0.86 | MAPK1 (0.73) | MAPK1NOD2ALDH1A1THRBSMN1; SMN2 | |
| SCHEMBL6552473 | 0.86 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBSMN1; SMN2 | |
| SCHEMBL57604 | 0.86 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBSMN1; SMN2 | |
| SCHEMBL20516489 | 0.86 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBSMN1; SMN2 | |
| SCHEMBL57603 | 0.86 | MAPK1 (1.00) | MAPK1NOD2ALDH1A1THRBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 604 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240091277-A1 | Perioperative Innate Immune Priming in Cancer Therapy | QU BIOLOGICS INC (CA) | 2024-03-21 | — | — | US | claimed |
| CN-117016573-A | Biological bacteriostat, and preparation method and application thereof | 国纳之星(上海)纳米科技发展有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-116218532-A | Method for preparing heavy metal contaminated soil activator from agricultural rural waste | 福州大学 | 2023-06-06 | — | — | CN | claimed |
| CN-116115742-A | Bioactive enzyme and protein-mimetic preparation for resisting and inhibiting bacteria and sterilizing | 鑫昱恒(北京)生物科技有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-116042329-A | Formula of laundry detergent containing marine bioactive enzyme and preparation method of laundry detergent | 广东闪立净实业集团有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-114948807-A | Itching relieving repair liquid and preparation method thereof | 深圳市美格天化生物科技有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-113773934-A | Brewing method of momordica grosvenori wine | 惠州市惠城区健生生态农业基地有限公司 | 2021-12-10 | — | — | CN | claimed |
| US-20210052645-A1 | Innate Targeting of Adoptive Cellular Therapies | QU BIOLOGICS INC. (CA) | 2021-02-25 | — | — | US | claimed |
| US-20190134172-A1 | Therapeutically Triggering an Innate Immune Response in a Target Tissue | QU BIOLOGICS INC. (CA) | 2019-05-09 | — | — | US | claimed |
| WO-2018085937-A1 | MANAGING SITE SPECIFIC IBD IMMUNOTHERAPIES | QU BIOLOGICS INC. (CA) | 2018-05-17 | — | — | WO | claimed |
| WO-1996009063-A1 | USE OF MURAMYL PEPTIDE COMPOUNDS | PEPTECH(UK) LIMITED (GB) | 1996-03-28 | — | — | WO | claimed |
| EP-0615522-A1 | MURAMYL COMPOUNDS FOR TREATMENT OF SEPTIC SHOCK | PEPTECH (UK) LIMITED (GB) | 1994-09-21 | — | — | EP | claimed |
| EP-0135376-B1 | POLYOXYPROPYLENE-POLYOXYETHYLENE BLOCK POLYMER BASED ADJUVANTS AND VACCINES USING THEM | SYNTEX (U.S.A.) INC. (US) | 1990-11-07 | — | — | EP | claimed |
| US-RE32992-E | THERAPY FOR INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS | Fujisawa Pharaceutical Co., Ltd. (JP) | 1989-07-18 | — | — | US | claimed |
| EP-0100734-B1 | PROCESS FOR THE SEPARATION OR PURIFICATION OF A SLEEP PROMOTING FACTOR FROM A BIOLOGICAL SOURCE BY IMMUNOLOGICAL REACTION OF THE ANTIGEN-ANTIBODY KIND | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1986-12-17 | — | — | EP | claimed |
| EP-0128097-A1 | Immunostiumulating derivatives, their preparation and their use as medicines | Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1984-12-12 | — | — | EP | claimed |
| EP-0027260-A2 | Peptides, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-04-22 | — | — | EP | claimed |
| EP-0025842-A2 | Peptides, process for their preparation, their pharmaceutical compositions and their intermediates | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-04-01 | — | — | EP | claimed |
| US-4186194-A | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1980-01-29 | — | — | US | claimed |
| US-4094971-A | ACYLATED PEPTIDOGLYCANE | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (FR) | 1978-06-13 | — | — | US | claimed |